The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10372 malaria professionals are enjoying the free benefits of MalariaWorld today

prospective cohort

Artenimol–piperaquine in children with uncomplicated imported falciparum malaria: experience from a prospective cohort

December 17, 2019 - 16:36 -- Open Access
Author(s): 
Lauren Pull, Jean-Marc Lupoglazoff, Matthew Beardmore, Jean-François Michel, Pierre Buffet, Olivier Bouchaud and Jean-Yves Siriez
Reference: 
Malaria Journal 2019 18:419, 16 December 2019

Although malaria remains one of the major public health threats in inter-tropical areas, there is limited understanding of imported malaria in children by paediatricians and emergency practitioners in non-endemic countries, often resulting in misdiagnosis and inadequate treatment. Moreover, classical treatments (atovaquone-proguanil, quinine, mefloquine) are limited either by lengthy treatment courses or by side effects. Since 2010, the World Health Organization (WHO) has recommended the use of oral artemisinin-based combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria worldwide. The benefits of artenimol–piperaquine in children have been validated in endemic countries but experience remains limited in cases of imported malaria.

Subscribe to RSS - prospective cohort